Intervention not reported
Adverse events · acute treatment of migraine in adolescents
The intervention showed no clear difference in adverse events (moderate certainty).
1 finding from 1 review
All‐cause mortality · patients with initial treatment of HIV infection in antiretroviral‐naive individuals
It is very uncertain whether d4T changes mortality compared with AZT (very low certainty).
1 finding from 1 review
Clinical progression · patients with initial treatment of HIV infection in antiretroviral‐naive individuals
d4T showed no clear difference in clinical progression compared with AZT (low certainty).
1 finding from 1 review
Severe adverse events · patients with initial treatment of HIV infection in antiretroviral‐naive individuals
d4T showed no clear difference in severe adverse events compared with AZT (low certainty).
1 finding from 1 review
Virologic response · patients with initial treatment of HIV infection in antiretroviral‐naive individuals
d4T showed no clear difference in virologic response compared with AZT (low certainty).
1 finding from 1 review
Adherence/tolerability/retention · patients with initial treatment of HIV infection in antiretroviral‐naive individuals
d4T showed no clear difference in adherence/tolerability/retention compared with AZT (low certainty).
1 finding from 1 review
Immunologic response · patients with initial treatment of HIV infection in antiretroviral‐naive individuals
1 finding from 1 review
Duration of oxygen therapy (hours) · patients with the management of transient tachypnea of the newborn
1 finding from 1 review
Need for mechanical ventilation · patients with the management of transient tachypnea of the newborn
It is very uncertain whether epinephrine changes need for mechanical ventilation (yes/no) compared with placebo, no treatment or any other drugs (very low certainty).
1 finding from 1 review
Initiation of oral feeding (days) · patients with the management of transient tachypnea of the newborn
1 finding from 1 review
Pain intensity VAS (0 to 100; 0 = no pain, 100 = worst pain) · patients with rheumatoid arthritis
1 finding from 1 review
Improvement Global improvement on 5‐point scale (very good/good/fair/poor/very poor) · patients with rheumatoid arthritis
It is very uncertain whether balneotherapy changes improvement Global improvement on 5‐point scale (very… compared with drug treatment (very low certainty).
1 finding from 1 review
Physical disability Not reported · patients with rheumatoid arthritis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Tender joints Number of painful joints Scale from 0 to 28 · patients with rheumatoid arthritis
1 finding from 1 review
Swollen joints Number of swollen joints Scale from 0 to 28 · patients with rheumatoid arthritis
1 finding from 1 review
Withdrawal due to serious adverse events Not reported · patients with rheumatoid arthritis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse events Not reported · patients with rheumatoid arthritis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Documented PCP infections Clinical and microbiological criteria · patients with Pneumocystis pneumonia (PCP) in non‐HIV immunocompromised patients
1 finding from 1 review
PCP‐related mortality Clinical only · patients with Pneumocystis pneumonia (PCP) in non‐HIV immunocompromised patients
TMP/SMX may leads to lower PCP‐related mortality Clinical only compared with placebo, no treatment or non‐PCP drug (low certainty).
1 finding from 1 review
Abnormal Involuntary Movement Scale LOCF at week 12 A physician‐administered rating scale with 12 items to measure tardive dyskinesia Scale from 0 to 40 · patients with an acute manic or mixed episode
1 finding from 1 review
no estimate extracted
634 participants
Low